Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peroxiredoxin 3 pseudogene 2 (PRDX3P2) is a pseudogene, meaning it is a DNA sequence similar to the functional PRDX3 gene but is generally not transcribed into a functional protein[4][5]. There is no evidence it encodes an active protein or plays a direct role in cellular physiology, disease processes, or therapeutic mechanisms. The biologically active and clinically relevant form is Peroxiredoxin 3 (PRDX3), a mitochondrial antioxidant enzyme involved in detoxifying peroxides and associated with spinocerebellar ataxia type 32, but PRDX3P2 itself is not considered an active therapeutic target or biologically functional molecule[1][2][3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peroxiredoxin 3 pseudogene 2 (PRDX3P2).